AWM Investment Company’s Alto Neuroscience ANRO Stock Holding History

AWM Investment Company’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.82M	Sell	170,000 -55,000	-24%	-$1.02M	0.42%	54
2025 Q4	$4M	Sell	225,000 -55,483	-20%	-$699K	0.39%	68
2025 Q3	$1.13M	Hold	280,483	–	–	0.11%	91
2025 Q2	$617K	Sell	280,483 -621,501	-69%	-$1.48M	0.07%	92
2025 Q1	$1.95M	Buy	901,984 +214,153	+31%	+$766K	0.27%	71
2024 Q4	$2.91M	Buy	687,831 +128,100	+23%	+$799K	0.35%	58
2024 Q3	$6.4M	Buy	559,731 +230,500	+70%	+$2.82M	0.78%	45
2024 Q2	$3.52M	Buy	329,231 +30,084	+10%	+$392K	0.48%	58
2024 Q1	$4.59M	Buy	+299,147	New	+$4.68M	0.6%	51

Other funds holding ANRO

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

SSC

Spruce Street Capital New York $416M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AWM Investment Company's ANRO Position: Q1 2026 in Review

AWM Investment Company reduced its Alto Neuroscience (ANRO) stake by 24% in Q1 2026, selling an estimated $1.02M and leaving 170,000 shares worth $3.82M. The position accounts for 0.42% of the portfolio, ranked #54.

AWM Investment Company first reported a position in ANRO in Q1 2024 and has held it in 9 quarters since. The position peaked at $6.4M in Q3 2024. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

AWM Investment Company held 170,000 shares of Alto Neuroscience worth $3.82M as of Q1 2026.
AWM Investment Company sold 55,000 Alto Neuroscience shares in Q1 2026, an estimated $1.02M.
Alto Neuroscience made up 0.42% of AWM Investment Company's portfolio in Q1 2026, its #54 holding.
AWM Investment Company first reported a position in Alto Neuroscience in Q1 2024 and has held it in 9 quarters since.
AWM Investment Company's Alto Neuroscience position peaked at $6.4M in Q3 2024.
110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.